The Flowflex Antigen Rapid Test is a lateral flow test that is designed to detect nucleocapsid protein antigen from SARS-CoV-2. Tested from nasal swab specimens directly from individuals who are suspected of an active COVID-19 within the first seven days of the onset of symptoms.
Reduce transmission and outbreaks - early detection will allow projects to act quickly preventing the spread of infection.
Avoiding unnecessary absenteeism - regular testing will prevent workers being placed in unnecessary self-isolation.
Reassuring the workforce - As part of COVID-19 risk assessment measures demonstrating the commitment to providing a safe working environment in these challenging times.
Fast results in 15 minutes.
Excellent performance compared to molecular PCR methods and room temperature storage.
The 15-20 minute rapid antigen test has Sensitivity: 97.1%, Relative Specificity: 99.6% and Accuracy: 99.3%.